Pembrolizumab aids survival with high-risk endometrial cancer
Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published online Oct. 16 in the Journal of Clinical ...
Oct 21, 2024
0
0